Mesa Laboratories Inc
NASDAQ:MLAB

Watchlist Manager
Mesa Laboratories Inc Logo
Mesa Laboratories Inc
NASDAQ:MLAB
Watchlist
Price: 116.45 USD 2.49%
Market Cap: 632.3m USD
Have any thoughts about
Mesa Laboratories Inc?
Write Note

Mesa Laboratories Inc
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Mesa Laboratories Inc
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Mesa Laboratories Inc
NASDAQ:MLAB
Current Portion of Long-Term Debt
$100.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
42%
Becton Dickinson and Co
NYSE:BDX
Current Portion of Long-Term Debt
$2.2B
CAGR 3-Years
63%
CAGR 5-Years
11%
CAGR 10-Years
27%
Boston Scientific Corp
NYSE:BSX
Current Portion of Long-Term Debt
$1.7B
CAGR 3-Years
85%
CAGR 5-Years
5%
CAGR 10-Years
88%
Stryker Corp
NYSE:SYK
Current Portion of Long-Term Debt
$2.2B
CAGR 3-Years
361%
CAGR 5-Years
33%
CAGR 10-Years
11%
Abbott Laboratories
NYSE:ABT
Current Portion of Long-Term Debt
$1.6B
CAGR 3-Years
29%
CAGR 5-Years
5%
CAGR 10-Years
23%
Intuitive Surgical Inc
NASDAQ:ISRG
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Mesa Laboratories Inc
Glance View

Market Cap
631.1m USD
Industry
Health Care

Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 506 full-time employees. The firm operates through four segments, Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments, and Continuous Monitoring. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators which are used to assess the effectiveness of sterilization and disinfection processes in the hospital, medical device, and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Instruments segment designs, manufactures, and markets quality control hardware and disposable products. The Continuous Monitoring segment develops, and markets systems which are used to monitor various environmental parameters such as temperature, humidity, and differential pressure.

MLAB Intrinsic Value
120.98 USD
Undervaluation 4%
Intrinsic Value
Price

See Also

What is Mesa Laboratories Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
100.8m USD

Based on the financial report for Sep 30, 2024, Mesa Laboratories Inc's Current Portion of Long-Term Debt amounts to 100.8m USD.

What is Mesa Laboratories Inc's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
42%

Back to Top